A phase 2 study in children will also start early in ... gradually adding new versions of Prevnar that expand the number of serotypes covered, but analysts think that position is now under threat.

Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Already facing one rival to its blockbuster pneumococcal vaccine Prevnar, Pfizer could have another to contend with, after Affinivax reported positive phase 2 results with its ASP3772 candidate ...

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

Prevnar revenues were in line with the Zacks ... Paxlovid revenues were $727 million in the quarter against negative $3.2 billion in the year-ago quarter. Paxlovid revenues beat the Zacks ...

Additionally, for the same year, the company recorded $2.9 billion in intangible asset ... Going into 2026, products like Eliquis and Prevnar-13 will lose their patents in the US.

Representative Jefferson Shreve (R-Indiana) recently bought shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March ...

The plan is to sell 2.4 million shares priced at $5 a pop ... to the currently approved Streptococcus pneumoniae vaccines Prevnar, Pneumovax and Vaxneuvance. AV0328 has completed phase 1 and ...

30.2 gigawatts of electric generating capacity ... FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands Biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel ...

Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the appointment of Mikael Dolsten, M.D., Ph.D., former Chief Scientific Officer, President, Pfizer Research & Development, ...

Estimated vaccination costs at the Fayette County Health Department, for people paying out of pocket. Most health insurance plans are required to pay for recommended vaccinations. If you're not sure ...